An observational study in Cardiovascular-kidney-metabolic (CKM) and Cardiovascular-kidney-metabolic Syndrome, sponsored by Karamanoğlu Mehmetbey University. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-07-30.
Sponsored by Karamanoğlu Mehmetbey University · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 54 studies in Metabolic Syndrome with a site in Turkey — 14 open to participants now, 16 under way, none of them phase 3. Metabolic Syndrome · Turkey.
Among the 54 studies in Metabolic Syndrome with a site in Turkey, this one is the 27th largest by planned enrollment of the 34 observational ones that give a count, is one of 10 that started in 2026, is one of 34 observational ones, reaches primary completion later than 7 of the 15 other live ones, and was the 51st registered.
2,119 studies on the registry are indexed under Metabolic Syndrome; 350 are open to participants now.
Browse Metabolic Syndrome studies →14 of the 54 studies in Metabolic Syndrome with a site in Turkey are open now. Recruiting first, the newest first:
Sisli Hamidiye Etfal Training and Research Hospital · Sites in Turkey
Ages 40–75
Abant Izzet Baysal University · Sites in Turkey
Ages 18–65
Yaşar Bayındır, MD · Sites in Turkey
Ages 18+ · Healthy volunteers
Istanbul University - Cerrahpasa · Sites in Turkey
Ages 18–50 · Healthy volunteers
Havva Betül Bacak · Sites in Turkey
Ages 18–45 · Women only · Healthy volunteers
A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →
Of the 234 Metabolic Syndrome studies recruiting now, 70 (30%) set no upper age limit and 135 (58%) stop at 75 or younger; 20 take children under 18; 81 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
54 studies; the count open now beside each. This study's row is marked.
First in 2006; this study’s year is marked. 10 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 80 is below the median of 196 across 497 observational studies indexed under Metabolic Syndrome.
Median enrollment 76 across the 20 interventional studies, 102 across the 34 observational. Of the 33 that completed or were terminated, 4 (12%) have results posted.
This tab as a report to print or save as PDF → With an account.
5 of 54 have an industry lead sponsor. The 10 most frequent:
Karamanoğlu Mehmetbey University is the lead sponsor of 71 studies on the registry; 18 are open to participants now.
Karamanoğlu Mehmetbey University has 1 study filed under Metabolic Syndrome — fewer than ten, so there is no comparison to draw.
6 of the studies in Metabolic Syndrome with a site in Turkey that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07890155Sisli Hamidiye Etfal Training and Research HospitalEffect of Resistance Exercises on Serum IGF-1 Levels in Knee Osteoarthritis | 2026-12-01 |
| NCT07643376Toros UniversityEvaluation of Metabolic Parameters, Intestinal Permeability and Gastrointestinal Symptoms After Bariatric Surgery in Body Weight Management | 2027-01-01 |
| NCT07942415Recep Tayyip Erdogan University Training and Research HospitalStress Levels Periodontitis and Metabolic Syndrome | 2027-03-15 |
| NCT07731360Kayseri City HospitalNon-Invasive Diagnostic Panel for MASLD in Children With Obesity | 2027-04-01 |
| NCT07731373Kayseri City HospitalBiomarker Panel for PCOS-Associated Liver Steatosis in Adolescent Girls (COMPASS-pedPCOS) | 2027-04-30 |
Add all 6 to your calendar (.ics) → With an account.
Among the 54 studies in Metabolic Syndrome with a site in Turkey, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Cardiovascular-Kidney-Metabolic (CKM) syndrome is a recently defined clinical syndrome characterized by the coexistence and interaction of cardiovascular disease, chronic kidney disease, and metabolic disorders, including obesity, dyslipidemia, insulin resistance, and type 2 diabetes mellitus. Individuals with CKM syndrome commonly exhibit vascular dysfunction, endothelial impairment, arterial stiffness, and an increased risk of cardiovascular morbidity and mortality. Although exaggerated blood pressure response during exercise has been recognized as an early marker of future hypertension and adverse cardiovascular outcomes, its relationship with aortic stiffness in patients with CKM syndrome has not been adequately investigated.
The aim of this observational study is to evaluate the association between blood pressure response during a clinically indicated exercise stress test and aortic stiffness in adults with CKM syndrome. Eighty patients with physician-diagnosed CKM syndrome who are referred for routine exercise stress testing in the cardiology outpatient clinic will be enrolled. Blood pressure will be measured immediately before and after the exercise test. Aortic stiffness will be assessed using transthoracic echocardiography by calculating the aortic stiffness index (β-index) from systolic and diastolic aortic diameters and concurrent blood pressure measurements. Demographic characteristics, anthropometric measurements, cardiovascular risk factors, medication use, lifestyle characteristics, and clinical data will also be collected. The findings may clarify whether blood pressure response during routine exercise testing can serve as a simple, non-invasive indicator of increased aortic stiffness and improve cardiovascular risk stratification in individuals with CKM syndrome.
The study population will consist of adults aged 18 years and older with a diagnosis of Cardiovascular-Kidney-Metabolic (CKM) syndrome who are referred to the cardiology outpatient clinic and scheduled for a clinically indicated exercise stress test as part of routine clinical care.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Adults diagnosed with Cardiovascular-Kidney-Metabolic (CKM) syndrome who are referred by a cardiologist for a clinically indicated exercise stress test as part of routine care. Participants undergo routine exercise stress testing and transthoracic echocardiography for assessment of aortic stiffness. Blood pressure response during exercise and aortic stiffness parameters are evaluated to investigate their association.
Association Between the Pre-to-Post Exercise Change in Blood Pressure and Aortic Stiffness
The association between the change in blood pressure from immediately before to immediately after a clinically indicated exercise stress test and the aortic stiffness index (β-index) will be evaluated in adults with Cardiovascular-Kidney-Metabolic syndrome. Systolic and diastolic blood pressure will be measured immediately before and immediately after the exercise test. Aortic stiffness will be calculated using systolic and diastolic aortic diameters obtained by transthoracic echocardiography together with concurrent blood pressure measurements.
Time frame: During a single study visit: immediately before and immediately after the exercise stress test
Plan to share: No
Started Jul 2026 (actual). Primary completion is estimated for Sep 2026, 2 months after the start.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Karamanoğlu Mehmetbey University